Scholarly Index
Julie Byrne
GlaxoSmithKline (United States); 464 total citations; 48 total publications; best world rank #89
GlaxoSmithKline (United States)
464Total citations
48Total publications
13H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Capital Investment and Risk Analysis | 2021-2025 | 89 | US 12 | 69.45 |